Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy

Frontiers in Immunology
Misako MatsumotoTsukasa Seya

Abstract

Pattern recognition receptors (PRRs) play a crucial role in the innate immune system and contribute to host defense against microbial infection. PRR-mediated antimicrobial signals provide robust type-I IFN/cytokine production and trigger inflammation, thereby affecting tumor progression and autoimmune diseases. Accumulating evidence demonstrates that among the PRRs, only the signaling pathway of endosomal toll-like receptor 3 (TLR3) induces no systemic inflammation and mediates cross-priming of antigen-specific CD8+ T cells by dendritic cells. Treatment with a newly developed TLR3-specific ligand, ARNAX, along with tumor-associated antigens (TAAs), induces tumor-specific cytotoxic T lymphocytes, modulates the tumor microenvironment to establish Th1-type antitumor immunity, and leads to tumor regression without inflammation in mouse tumor models. Combination therapy using ARNAX/TAA and PD-1/PD-L1 blockade potently enhances antitumor response and overcomes anti-PD-1/PD-L1 resistance. In this review, we will discuss the TLR3-mediated signaling in antitumor immunity and its application to cancer immunotherapy.

References

Apr 22, 2003·Nature Medicine·Tyler J CurielWeiping Zou
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Feb 16, 2005·Nature·Oliver SchulzCaetano Reis e Sousa
Jan 21, 2006·Nature Immunology·Taro Kawai, Shizuo Akira
Feb 24, 2006·Nature Reviews. Immunology·Martin F BachmannBenjamin J Marsland
May 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Leonid GitlinMarco Colonna
Oct 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masashi ShingaiTsukasa Seya
Nov 6, 2007·Immunological Reviews·Arthur M Krieg, Jörg Vollmer
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kenji FunamiMisako Matsumoto
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Feb 12, 2008·Advanced Drug Delivery Reviews·Misako Matsumoto, Tsukasa Seya
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kiyoharu ItohMisako Matsumoto
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Je-In YounDmitry I Gabrilovich
Feb 3, 2009·Cancer Immunology, Immunotherapy : CII·Tsukasa Seya, Misako Matsumoto
Feb 23, 2010·Current Opinion in Immunology·Elisa PeranzoniVincenzo Bronte
Apr 27, 2010·The Journal of Biological Chemistry·Megumi TatematsuMisako Matsumoto
May 15, 2010·Current Opinion in Immunology·M Lamine MbowRino Rappuoli
May 19, 2010·The Journal of Experimental Medicine·Sarah L JongbloedKristen J Radford
May 19, 2010·The Journal of Experimental Medicine·Lionel Franz PoulinCaetano Reis e Sousa
Jan 19, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ivett JelinekDavid M Segal
Sep 21, 2011·The Journal of Experimental Medicine·Mercedes B FuertesThomas F Gajewski
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki ShimeTsukasa Seya
Jun 26, 2012·Nature Reviews. Immunology·Christophe J Desmet, Ken J Ishii
Aug 31, 2012·Oncoimmunology·Lorenzo GalluzziGuido Kroemer
Oct 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul SabbatiniSacha Gnjatic
Nov 8, 2012·Biochemical and Biophysical Research Communications·Shinichi MochizukiKazuo Sakurai
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
Jan 19, 2013·Science·Lisa M CoussensA Karolina Palucka
Apr 13, 2013·Current Opinion in Immunology·Thomas F GajewskiStefani Spranger
May 16, 2013·Nature Communications·Megumi TatematsuMisako Matsumoto
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 28, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael Y GernerMatthew F Mescher
Sep 21, 2013·Nature Immunology·Thomas F GajewskiYang-Xin Fu
Nov 12, 2013·Trends in Immunology·Andrea Schietinger, Philip D Greenberg
Jan 25, 2014·Nature Reviews. Cancer·Pierre G CoulieThierry Boon
Jul 17, 2014·The New England Journal of Medicine·Y LiuR Goldbach-Mansky
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tetje C van der SluisCornelis J M Melief
Jan 17, 2015·Current Opinion in Immunology·Mitsutoshi YoneyamaTakashi Fujita

❮ Previous
Next ❯

Citations

Nov 7, 2019·Frontiers in Immunology·Zuzanna Urban-WojciukDavid R Goodlett
Apr 1, 2020·Expert Opinion on Biological Therapy·Misako MatsumotoTsukasa Seya
Apr 13, 2019·Archivum Immunologiae Et Therapiae Experimentalis·Jan ŻeromskiIwona Mozer-Lisewska
Jul 15, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P L SmithA G Dalgleish
Dec 14, 2018·Oncoimmunology·Melody SmithLorenzo Galluzzi
Mar 13, 2018·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Tsukasa SeyaMisako Matsumoto
Jun 4, 2019·Frontiers in Immunology·Rodrigo Barbosa de Aguiar, Jane Zveiter de Moraes
Oct 28, 2020·International Journal of Dermatology·Marina P TorrealbaMaria N Sato
Jul 16, 2019·Advanced Drug Delivery Reviews·Tsukasa SeyaMisako Matsumoto
Oct 30, 2020·Journal of Hematology & Oncology·Eric PowersTian Zhang
May 1, 2021·Cancers·Natalia GeorgantzoglouStamatios Theocharis
Jun 1, 2021·Frontiers in Immunology·Marcia ManterolaAndrea Calixto
May 25, 2021·Frontiers in Immunology·Isabella LurjeLinda Hammerich
Jul 23, 2020·Current Pharmaceutical Design·Arunaksharan NarayanankuttyJoice T Job
Jun 20, 2021·Immunologic Research·Asma KomalAttalla F El-Kott
Jun 15, 2021·Journal of Immunology Research·Saghar PahlavanneshanMohsen Basiri
Feb 19, 2019·Cellular Immunology·Pollyana Guimarães de OliveiraMilton Adriano Pelli de Oliveira
Nov 8, 2018·Journal of Innate Immunity·Megumi TatematsuMisako Matsumoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.